Artificial intelligence may be perceived as a threat to some physicians, but, according to research presented at the Radiological Society of North America’s annual meeting in Chicago, it could have some real use for cardiologists.

One of the nation’s largest health insurers is using AI to help persuade patients to get their seasonal flu shot, The Wall Street Journal reported.

Healthcare institutions are encountering a growing number of gadolinium deposition disease cases. One expert recently discussed why radiologists should use current data to shed light on the topic and minimize their liability risk.

The FDA is testing metformin, a popular drug used to treat type 2 diabetes, for carcinogenic impurities.

MaxQ AI has achieved ISO 27001 certification, meaning the Tel Aviv, Israel-based company fully complies with the internationally recognized information security standard.

Beta-blocker use was linked to an increased risk of heart failure hospitalizations in a recent study of patients with “stiff heart” HF—a concerning finding considering the majority of such patients take the drugs as part of their care regimen.

Drugs commonly used to treat diabetes are being tested for unsafe levels of carcinogens by the FDA.

Implementing AI solutions into clinical practice can be a long, challenging process, according to a presentation at RSNA 2019 in Chicago. When the time comes, some providers will have the patience to make it all the way to the finish line—while some won’t.  

Researchers with the National Institute of Environmental Health Sciences recently made that discovery by analyzing data from almost 47,000 individuals. 

Women who use oral contraceptives have a “significantly” smaller area of the brain that’s responsible for regulating everything from body temperature to mood, appetite, sex drive and sleep cycles.